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Influence of the assessment of defect severity and 
intravenous nitrate administration during tracer 
injection on the detection of viable hibernating 
myocardium with data-based quantitative 
technetium 99m-labeled sestamibi single-photon 
emission computed tomography 
Roberto Sciagra, MD, Gianni Bisi, MD, Giovanni M. Santoro, MD, 
Marco Agnolucci, MD, Orazio Zoccarato, PhD, and Pier Filippo Fazzini, MD 
Background. This study aimed to verify whether the assessment of defect severity and the 
infusion of nitrates during t racer  injection improve the capability of data-based ~gmTc-labeled 
sestamibi single-photon emission computed tomography (SPECT) to recognize hibernating 
myocardium. 
Methods and Results. Of 66 asynergic coronary territories in 40 patients with left 
ventricular dysfunction, 28 had postrevascularization functional recovery (hibernating) and 38 
had unchanged dysfunction (fibrotic). Defect severity was lower in the hibernating than in the 
fibrotic territories on both baseline (p < 0.01) and nitrate SPECT (p < 0.002). Nitrate was 
superior  to baseline SPECT to differentiate the hibernating from the fibrotic territories 
(sensitivity 96% vs 75%, p < 0.05; receiver-operating characteristic curve area 0.75 vs 0.63, 
p < 0.001) and to identify the patients with improved left ventricular ejection fraction (receiver- 
operating characteristic curve area 0.68 vs 0.58; p < 0.05). 
Conclusions. The analysis of defect severity in combination with nitrate infusion clearly 
improves the value of 9~mTc-labeled sestamibi SPECT for the recognition of hibernating 
myocard ium and the prediction of postrevascularization recovery. (J Nucl Cardiol 1996;3:221- 
30.) 
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99mTc-labeled sestamibi is at present the sole 99mWc- 
labeled myocardial perfusion tracer to have gained wide- 
spread clinical acceptance. It offers various advan- 
tages over 2°'Tl: in particular it has  optimal features 
for single-photon emission computed tomography 
(SPECT). r 99mTc-labeled sestamibi SPECT has been 
demonstrated to be accurate in the detection of coronary 
artery disease, ~ and its reliability has beer~ increased by 
the availability of validated methods for the quantitative 
analysis of SPECT according to the comparison with 
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databases of normal control subjects. 2 However, previ- 
ous data obtained with planar imaging suggested that 
rest ~9~Tc-labeled sestamibi uptake defects could be 
found in regions with preserved wall motion) More 
recently, specific concern has been expressed about the 
capability of rest 9~mTc-labeled sestamibi to detect viable 
hibernating myocardium in asynergic regions. 4-9 On the 
other hand, other reports suggested that the quantifica- 
tion of the abnormal uptake (defect severity) might be 
helpful to differentiate between viable and nonviable 
myocardium.3"8" 10 
Another major point in dealing with the problem of 
myocardial viability is the choice of a suitable imaging 
protocol, as shown by previous experiences with 
20JT1.J,-~3 Most studies 3-7'9"m that used 99mTc-labeled ses- 
tamibi as a viability tracer examined the results of only 
standard rest imaging. On the other hand, the collection 
of redistribution images 8 may be promising to im- 
prove the detection of myocardial viability with 99roTe- 
labeled sestamibi. This indicates that modifications of 
the usual imaging protocol for rest 99mTc-labeled sesta- 
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mibi SPECT could be helpful for the detection of 
hibernating myocardium. Data obtained with 2°IT1 and 
99mTc-labeled teboroxime suggest that the combination 
of tracer injection with the acute administration of 
nitrates could be useful. I4'15 
The aim of this study was to evaluate the relation- 
ship between myocardial viability and the severity of 
significant uptake defects at rest in data-based quantita- 
tive 99mTc-labeled sestamibi SPECT. Moreover, we in- 
vestigated the possibility of increasing the recognition of 
myocardial viability with 99mTc-labeled sestamibi by 
performing the tracer injection in combination with the 
infusion of nitrates. 
METHODS 
Patient Population. Among all patients who were re- 
ferred for myocardial perfusion imaging, 48 consecutive pa- 
tients with a history of prior myocardial infarction, low- 
threshold effort angina, and left ventricular dysfunction (left 
ventricular ejection fraction [LVEF] <50%) and who were 
scheduled for a revascularization procedure were prospectively 
enrolled. Part of the data of 19 of these patients was included 
in a previous report? 6 Patients whose myocardial infarction 
dated back to less than 3 months, with a history of unstable 
angina of less than 3 months, with cardiac conditions other 
than coronary artery disease or who had already undergone a 
revascularization procedure were excluded. After enrollment, 
six patients refused the proposed intervention, one had a 
perioperative infarction, and in one patient the preoperative 
studies were incomplete. Therefore the final study cohort 
included 40 patients. 
Study Protocol. The study protocol had been approved 
previously by the ethics committee of our institution. Informed 
consent was obtained from all patients. Before revasculariza- 
tion, all patients underwent cardiac catheterization with coro- 
nary angiography, baseline two-dimensional echocardiography 
for the assessment of regional wall motion, first-pass radionu- 
clide angiocardiography for the calculation of LVEE and 
baseline rest and nitrate myocardial perfusion SPECT with 
99mTc-labeled sestamibi. In patients who used nitrates, the drug 
was discontinued 48 hours before the scintigraphic studies. All 
other medications remained unchanged. None of the patients 
were taking ~-blockers. All studies were completed within 1 
week, with the exception of cardiac catheterization, which was 
performed within 15 days. During the entire study period, the 
clinical conditions of all patients remained stable. After revas- 
cularization, regional wall motion was assessed by two-dimen- 
sional echocardiography and LVEF was measured by first-pass 
radionuclide angiocardiography. The postoperative evaluation 
was obtained after a minimum of 3 months in the case of 
coronary bypass grafting or after a minimum of 1 month and 
no later than 2 months in the case of coronary angioplasty. 
Restenosis was ruled out by exercise stress testing. 
Nitrate Imaging. The nitrate infusion was performed 
with the patient lying supine, under electrocardiographic and 
blood pressure monitoring. Isosorbide dinitrate (10 mg diluted 
in 100 ml isotonic saline solution) was infused at the rate of 
0.5 mg/min. As soon as the systolic blood pressure dropped 20 
mm Hg or greater or a systolic blood pressure value less than 
90 mm Hg was measured, 99mTc-labeled sestamibi was in- 
jected. If neither of these two criteria was fulfilled, the tracer 
was injected 15 minutes after the beginning of the infusion. 
The nitrate infusion was always maintained for at least 
2 minutes after tracer injection. None of the patients had 
adverse reactions to the nitrate infusion. 
Cardiac Catheterization. Coronary angiography was 
performed by the percutaneous femoral (Judkins) technique, 
acquiring multiple projections of each of the main coronary 
arteries. Two experienced observers, who had no knowledge of 
the clinical and scintigraphic data, evaluated each major epicar- 
dial vessel with callipers. Significant stenosis was considered if 
the lesion restricted the lumen 50% or greater. 
Regional Wall Motion Assessment. Both the preopera- 
tive and postoperative assessments of the regional wall motion 
and thickening were performed by two-dimensional echocar- 
diography. An Aloka SSD-870 echocardiograph with 2.5 to 3.5 
MHz transducers (Aloka Co., Ltd., Tokyo, Japan) was used. 
Patients were studied at rest in the left lateral decubitus 
position. Parasternal long-axis, parasternal short-axis at basal 
and midventricular levels, and apical two- and four-chamber 
views were obtained and recorded on videotape. The two 
studies were analyzed in random sequence by two experienced 
observers, blinded to the clinical, angiographic, and scinti- 
graphic data. The left ventricle was divided into 13 segments~7: 
a single apical segment plus six sections (anteroseptal, anterior, 
anterolateral, posterolateral, posteromedial, and posteroseptal), 
each subdivided into a basal and midventricular segment. The 
basal and midventricular anteroseptal, anterior, and anterolat- 
eral segments and the apex were attributed to the left anterior 
descending artery. The basal and midventricular posterolateral 
segments were assigned to the circumflex artery. The basal and 
midventricular posteromedial and posteroseptal segments were 
assigned to the right coronary artery. The wall motion and 
thickening of each segment were analyzed according to a 
semiquantitative score: 1 = normal, 2 = hypokinesis, 3 = akine- 
sis, and 4 = dyskinesis. ~7'~8 For each coronary territory a wall 
motion index (WMI) was calculated by dividing the total score 
of the related segments by the number of segments assigned to 
that territory. '8 Discrepancies between the two observers were 
resolved by consensus. According to their WMI, the vascular 
territories were classified as follows: 1 = normokinetic; greater 
than 1 and less than 1.5 = minimal asynergy; 1.5 or greater and 
less than 2 = moderate asynergy; and 2 or greater= severe 
asynergy, t~ Myocardial viability was considered to be ques- 
tionable in the coronary territories with WMI of 1.5 or greater. 
Among these territories, those that showed a WMI reduction 
after revascularization were considered to be hibernating; 
those that exhibited no changes or a worsening in wall motion 
were defined as fibrotic. A decrease in wall motion score of 
one grade or greater in at least one segment in the cases of the 
right coronary or left circumflex territory or in at least two 
contiguous segments in the case of the left anterior descending 
territory was required to define significant improvement in 
postrevascularization W M I .  6'm'r7'I8 
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Measurement of LVEF. LVEF was calculated with a 
first-pass study acquired during the injection of 99mTc-labeled 
sestamibi for baseline rest perfusion SPECT. First-pass radio- 
nuclide angiocardiography was acquired in the 30-degree right 
anterior oblique projection, with the patient supine, with an 
Elscint Apex SP4 gamma camera (Elscint Inc., Boston, Mass.) 
equipped with a low-energy all-purpose collimator, and a 20% 
window centered at the 140 keV photopeak of 99mTc. Twenty- 
five millicuries (925 MBq) 99mTc-labeled sestamibi was in- 
jected as a compact bolus according to our already-described 
procedure.~9 The quality of bolus was always found acceptable 
(full width at half maximum <1 second). The study was 
acquired in frame mode, with a x2 magnification factor. The 
LVEF was calculated from the background-subtracted time- 
activity curve of the representative cycle and the mean value of 
the two calculations used for the data analysis.~9 The follow-up 
first-pass study was acquired either in the context of a ~mTc- 
labeled sestamibi perfusion scintigraphy or as an isolated study 
with ~mTc-labeled pertechnetate. 
99~l'c-labeled Sestamibi Scintigraphy. SPECT was 
collected 60 minutes after Tcgm-labeled sestamibi injection. 9~° 
An Elscint Apex SP4 gamma camera equipped with an ultra- 
high-resolution collimator and a 20% window centered at the 
140 keV photopeak of 99mTc was used. Sixty projections of 20 
seconds each were acquired in step-and-shoot mode over a 
180-degree arc, with a zooming factor 1.4 and 64 x 64 ma- 
trixes. The image reconstruction was performed with back- 
projection without a preprocessing filter and with a Wiener 
reconstruction filter. No attenuation or scatter correction was 
used. The transaxial slices were realigned along the heart axis 
obtaining short-axis, vertical, and horizontal long-axis slices. 
For the quantitative evaluation of the SPECT images, the 
short-axis slices from the first slice with apical activity to the 
last one with activity at the base were used. Their count 
profiles were generated by computer software and plotted onto 
a two-dimensional volume-weighted polar map, which was 
subsequently divided into three territories corresponding to the 
distribution of the three main coronary arteries, z° The count 
profile of each patient was compared with a sex-specific 
database of rest ~mTc-labeled sestamibi studies performed on 
normal control subjects (subjects with either normal coronary 
angiograms or a <2.5% pretest probability of coronary artery 
disease on the basis of the Bayesan analysis of age, sex, 
symptoms, rest, and exercise electrocardiography). The lower 
limit of the normal range was set at 2.5 SDs below the mean 
of the sex-specific control group. 2'' The extent of the abnor- 
mality was expressed as a percent of the entire left ventricular 
wall and a percent of each single coronary territory involved. 
In the latter case, to be considered significant, a defect had to 
be greater than 12% of the left anterior descending and the 
circumflex territories and greater than 8% of the right coronary 
artery territory/-' For the assessment of defect severity, the 
number of standard deviations (with 0.5 SD steps) by which 
the counts in each pixel within the defect area were below the 
mean of the normal control subjects was iteratively estimated. 
In each pixel the resulting value could range from 0 (minimal 
severity, first iteration, counts =-2.5  SDs of the mean of 
normal) to 1 (maximal severity, last iteration, counts <-20 SDs 
of the mean of normal). The total defect severity was calcu- 
lated by multiplying the number of pixels within the defect by 
the severity value of each of them. 2° The total severity of all 
present defects was obtained and expressed as a percent of the 
entire left ventricular wall. The severity of each single defect 
was expressed as a percent of the maximal value possible 
within the involved coronary territory. 
Statistical Analysis, Data are expressed as appropriate 
as the mean + SD. The within-group comparisons were made 
with the Wilcoxon signed rank test for paired data and the 
between-group comparisons with the Mann-Whitney U test for 
unpaired data, with corrections for multiple comparisons as 
appropriate. The comparisons of proportions were made with 
the Fisher exact test. Receiver-operating characteristic (ROC) 
curves were calculated by variation of the cutoff values to 
compare the accuracy of the different imaging modalities, and 
Wilcoxon statistics were used to assess significance, z2 A value 
of p < 0.05 was considered significant. 
RESULTS 
Clinical, Angiographic, and Echocardiographic 
Data. The mean age of  the patients was 59 + 10 years 
(range 39 to 77 years). There were six women and 34 
men. The site of the prior myocardial  infarction was 
anterior in 26 and inferior in 22 cases (eight patients had 
two infarct sites each). The LVEF was 34.9% _+ 9.3% 
(range 16% to 49%) and was less than 40% in 29 
patients. All  patients were found to be affected by 
significant coronary artery disease ( !2  patients had 
one-vessel, 12 two-vessel, and 16 three-vessel disease). 
A total of 84 vessels had significant coronary artery 
obstruction. In the echocardiographic evaluation per- 
formed before revascularization, there were 66 coronary 
artery territories (all subtended by stenotic vessels) with 
a WMI  of 1.5 or greater and hence questionable vi- 
ability. 
Follow-Up Evaluation, Complete revascularization 
of all stenosed major epicardial vessels was obtained 
with multiple bypass grafting in 24 cases and coronary 
angioplasty in 16 cases. Perioperative infarction had 
been excluded in all patients on the basis of  the usual 
clinical, electrocardiographic, and enzymatic criteria. 
After revascularization, all patients reported an improve- 
ment in their anginal symptoms. The postrevasculariza- 
tion LVEF increased greater than 5% in 20 patients 
(from 35.4%_+ 8.7% to 42.9% + 7.1%) and remained 
unchanged or decreased in the remaining 20 patients 
(from 34 .6%+ 10.1% to 31.1%_+8.9%). Of the 66 
coronary territories with a W M I  of 1.5 or greater, 28 
showed a significant improvement in the wall motion 
pattern and were classified as hibernating and t h e  re- 
maining 38 were classified as fibrotic. Twenty-six of the 
hibernating territories were detected in the 20 patients 
who showed a postrevascularization increase in LVEE 
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Figure 1. Diagram shows mean + SD percent severity of sig- 
nificant uptake defects detected by baseline or nitrate SPECT 
in territories with prerevascularization WMI of 1.5 or greater 
but with postrevascularization recovery (hibernating) and in 
those with unchanged regional dysfunction (fibrotic). Signifi- 
cantly higher severity of latter defects can be appreciated. 
Data-Based Quantitative 99"Tc-Labeled $esta- 
mibi SPECT. The baseline perfusion images showed 
abnormal 99mTc-labeled sestamibi uptake of a significant 
extent as defined by the comparison with the normal 
database (47.4% + 26.9%) in 81 vascular territories, all 
with 50% or greater stenosis. Of these 81 territories, 17 
had a WMI less than 1.5 and 64 1.5 or greater by 
prerevascularization echocardiography. Two territories 
with a WMI of 1.5 or greater had normal 99mTc-labeled 
sestamibi uptake. All 28 hibernating territories were 
abnormal by baseline SPECT. The nitrate perfusion 
images showed abnormal 99mTc-labeled sestamibi uptake 
of a significant extent (51.4% + 23.2%; difference not 
significant vs baseline) in 64 vascular territories (differ- 
ence not significant vs baseline), including six with a 
WMI less than 1.5 and 58 with a WMI of 1.5 or greater 
in prerevascularization echocardiography. Only 22 of the 
28 hibernating territories showed a significant uptake 
defect in nitrate SPECT (p < 0.05 vs baseline). 
Analysis of Defect Severity and Recognition of 
Hibernating Myocardium. In baseline SPECT, a sig- 
nificantly lower percent severity of the uptake defects 
was demonstrated in the 28 hibernating territories com- 
pared with those without postrevascularization func- 
tional recovery: 22% + 17.7% (95% confidence interval 
[CI] = 15% to 29%) versus 39.9% + 23% (CI = 32.2% to 
47.5%; p < 0.01) (Figure 1). Also, in nitrate SPECT the 
Table 1. Value of the analysis of defect 
severity to predict the postrevascularization 
ou tcome of the territories with WMI greater  than 1.5 
Baseline SPECT (%) Nitrate SPECT (%) p Value 
PPV 62 68 NS 
NPV 78 96 0.05 
PA 70 79 NS 
PPV, Positive predictive value; NS, not significant; NPV, negative 
predictive value; PA, predictive accuracy. 
significant uptake defects found in the 22 hibernating 
territories had a significantly lower severity compared 
with those detected in the 36 fibrotic territories: 
18.3% +9.9% (CI = 13.8% to 22.8%) versus 39.3%_+ 
21.9% (CI = 32% to 46.6%; p < 0.002) (Figure 1). Fig- 
ure 2 shows the ROC curves calculated for both baseline 
and nitrate SPECT with different cutoff values of the 
percent severity to differentiate between the uptake 
defects, which included mainly hibernating from those 
that included mainly fibrotic myocardium. The defects 
with a lower percent severity were considered hibernat- 
ing together with those without a significant uptake 
defect. The area under the ROC curve was significantly 
larger with nitrate than with baseline SPECT (0.75 vs 
0.63; p < 0.001). An arbitrary cutoff value of 30% of the 
maximal severity appeared to give the best possible 
differentiation between the two groups in both baseline 
and nitrate SPECT. When this cutoff value was applied, 
the sensitivity of baseline rest 99mTc-labeled sestamibi 
imaging for the recognition of hibernating myocardium 
was 75%, and its specificity was 66%. The overall 
accuracy was 70%. In nitrate SPECT sensitivity was 
96% (p < 0.05 vs baseline), specificity 66%, and overall 
accuracy 79%. Table 1 shows the positive and negative 
predictive values of percent severity in baseline and 
nitrate SPECT according to the 30% cutoff. 
Figure 3 shows the example of a patient in whom 
the presence of viable myocardium within a hibernating 
territory was demonstrated by the analysis of defect 
severity in both baseline and nitrate SPECT. Figure 4 
shows consonance of baseline and nitrate SPECT in 
excluding the presence of viable hibernating myocar- 
dium in another patient. Finally, Figure 5 shows an 
example of disagreement between baseline and nitrate 
SPECT in recognizing a hibernating territory on the 
basis of the defect severity. 
Quantitative 99~Tc-Sestamibi SPECT and Pre- 
diction of Improvement in Global Left Ventricular 
Function. The possible relationship between the total 
percent severity of the uptake defects and the changes in 
LVEF observed after revascularization was also investi- 
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gated. In baseline SPECT the mean total percent severity 
in the 20 patients with a greater than 5% postoperative 
increase in LVEF was not significantly different from the 
value observed in the 20 patients with unchanged or 
worsened LVEF: 15.7% + 7.8% (CI = 12% to 19.4%) 
versus 18% + 10.9% (CI = 12.9% to 23%). Conversely, a 
significantly lower value was found in the first group with 
nitrate SPECT: 11.1% + 6.4% (CI = 8.1% to 14.1%) ver- 
sus 18.5%_+ 10.1% (CI= 13.8% to 23.2%) (p < 0.05). 
Furthermore, the baseline and nitrate total percent sever- 
ity of the unimproved patients was not significantly dif- 
ferent, whereas the nitrate total percent severity of the 
improved patients was significantly lower than the base- 
line value in the same patients (p < 0.002) (Figure 6). 
Figure 7 shows the ROC curves calculated for both base- 
line and nitrate SPECT according to different cutoff val- 
ues of total percent severity to differentiate between pa- 
tients with improved LVEF and patients with unchanged 
LVEE Nitrate SPECT gave better results than baseline 
SPECT, as demonstrated by the significantly larger area 
under the ROC curves: 0.68 versus 0.58 (p < 0.05). Table 
2 compares the predictive values of baseline and nitrate 
SPECT when the optimal cutoff value of percent severity 
was adopted for each imaging modality. 
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Figure 2. ROC curves for baseline and nitrate SPECT of 
diagnostic accuracy of percent severity in detection of hiber- 
nating myocardium within territories with moderate or severe 
regional dysfunction. 
DISCUSSION 
Positron emission tomography (PET) is considered 
the best available method for the recognition of viable 
hibernating myocardium, 2~'2~ but high costs and limited 
availability preclude its widespread use. 2°'T1 perfusion 
imaging according to appropriate acquisition protocols is 
a reliable alternative to PET for the issue of myocardial 
viability, but its lower accuracy has been demonstrated. ~4 
Experimental studies 25"26 have shown that 99mTc-labeled 
sestamibi uptake and retention require cell viability, but 
the comparisons with 2°1T1 or PET in humans ~5'7'8 suggest 
that ~gmTc-labeled sestamibi might underestimate viable 
myocardium. However, it is only by comparing results of 
~gmTc-labeled sestamibi with the most accurate index of 
the presence of hibernating myocardium, which is the 
detection of reversible dysfunction after adequate revas- 
cularization, that it is possible to define its value as a 
viability tracer. Conflicting conclusions have been re- 
ported. With quantitative planar ~gmTc-labeled sestamibi 
imaging, Marzullo et al. 6 showed that some segments 
with a decreased tracer uptake had a postrevascularization 
recovery and concluded that 99mTc-labeled sestamibi 
should be not used as a viability tracer. Conversely, Udel- 
son et al.'° demonstrated that the analysis of the severity 
of uptake defect in 99mTc-labeled sestamibi and 2°~T1 
SPECT achieved comparably good results so as to define 
the functional outcome of asynergic segments. Maublant 
et al., 9 performing qualitative evaluation of 99mTc-labeled 
sestamibi SPECT, found a rough relationship between 
tracer uptake score and presence of hibernating myo- 
cardium. 
As shown by our study, many viable territories (with 
normal or near-normal baseline wall motion or postrevas- 
cularization recovery) had a significant uptake defect in 
baseline 99mTc-labeled sestamibi SPECT. However, the 
capability of rest 99mTc-labeled sestamibi to detect viable 
hibernating myocardium improved when the severity of 
the uptake defects was considered. There was a significant 
difference in percent severity between the defects in terri- 
tories with postrevascularization functional recovery and 
those in territories with unchanged dysfunction. It was 
also possible to identify a cutoff point that differentiated 
most hibernating territories from the others and allowed a 
reasonable prediction of which territories would or would 
not benefit from a revascularization procedure. Our data 
support the results of Udelson et al. '° on the value of 
~9mTc-labeled sestamibi for the detection of hibernating 
myocardium when the degree of tracer uptake is assessed. 
Furthermore, the achieved predictive values are similar to 
those reported by Ragosta et al., '~ who obtained a 57% 
positive and 77% negative predictive value with quantita- 
tive planar rest-distribution 2°~T1 imaging. The advantage 
of our approach to quantitative assessment of severity is 
that the parameter is obtained by the comparison with a 
normal database and is related directly to the involved 
coronary vascular territory. 
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Figure 3. Polar map displays of patient with left anterior descending (Lad) obstruction and 
anteroapical akinesis. On left, nitrate study: upper left map depicts patient's count distribution; 
lower left map shows in white uptake defect (activity <2.5 SDs below normal limit); upper right 
map is database count distribution (mean map); uptake defect is shown in lower right panel. On 
right, baseline study is shown with same image disposition. Analysis of defect severity indicates 
that left anterior descending and left circumflex (Lcx) territories should be classified as viable in 
both baseline and nitrate SPECT. Left circumflex territory was normokinetic in prerevascularization 
echocardiogram; left anterior descending territory showed significant recovery after coronary 
angioplasty. (Rca, Right coronary artery.) 
We also evaluated the possibility of improving the 
capability of  99mTc-labeled sestamibi to detect viable 
hibernating myocardium by modifying the imaging pro- 
tocol for rest scintigraphy. Collecting a 4-hour 99myc- 
labeled sestamibi redistribution study, Dilsizian et al. 8 
had already demonstrated an increased consonance with 
2°lyl reinjection SPECT and PET. However, the clinical 
importance of  99mTc-labeled sestamibi redistribution re- 
mains questionable. 25 Furthermore, no correlation with 
the postrevascularization evolution of regional wall mo- 
tion was reported in that study. Alternatively, the admin- 
istration of nitrates at the time of 99mTc-labeled sestamibi 
injection could be considered, under the assumption that 
the increase in coronary blood flow 27 might improve 
tracer uptake in severely hypoperfused viable areas, as 
shown for 2°~T1 ~4 and 99mTc-labeled teboroxime. ~5 
In a prior report we had demonstrated that the 
nitrate-induced changes in extent of 99roTe-labeled ses- 
tamibi defects were significantly correlated with the 
presence of  viable hibernating myocardium? 6 In this 
study all 17 territories with an abnormal defect extent in 
the baseline images that became normal in nitrate 
SPECT included viable myocardium: 11 had a WM! less 
than 1.5 in the prerevascularization echocardiogram and 
six were hibernating. In spite of  that, a 99mTc-labeled 
sestamibi uptake defect of  significant extent was still 
observed in 22 of 28 hibernating territories. Thus when 
the nitrate images were examined separately and the 
nitrate-induced changes left out of consideration, the 
finding of a defect of  significant extent did not imply the 
absence of  myocardial viability and very limited advan- 
tage over baseline SPECT was registered. Conversely, 
the quantification of  defect severity in nitrate SPECT 
achieved better results than in baseline imaging, as 
demonstrated by the significantly larger ROC curve 
area.- With the same optimal cutoff point applied to the 
baseline images, the sensitivity of nitrate SPECT in 
identifying the hibernating territories was significantly 
higher (96% vs 75%; p < 0.05). The ROC analysis of the 
accuracy of  the total percent severity in the recognition 
of patients who had an improvement in the global left 
ventricular function showed significant superiority of  
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Figure 4. Polar map displays of patient with three-vessel disease who had inferior and inferolat- 
eral akinesis in preoperative echocardiogram. Image disposition and abbreviations are same as in 
Figure 3. Analysis of defect severity in both baseline and nitrate SPECT indicated that left 
circumflex and right coronary artery territories were not viable. After triple bypass grafting, patient 
showed improvement in anginal symptoms but no functional recovery in either territory. 
nitrate compared with baseline SPECT, with predictive 
values near those reported with 2°IT1 planar rest-redis- 
tribution.13 Moreover, for recovery of regional dysfunc- 
tion, the infusion of nitrates in combination with the 
analysis of  defect severity in 99mTc-labeled sestamibi 
SPECT allowed accuracy and predictive values that are 
higher than those reported with 2°IT1 planar rest-redis- 
tribution scintigraphy. '3 Particularly remarkable com- 
pared with previous studies of  99mTc-labeled sestamibi 
was the very high negative predictive value (96%). In 
addition, these results have been obtained leaving the 
nitrate-induced changes out of  consideration, which is 
an advance over our previous data. ~6 Hence there is no 
need to perform a baseline reference study. 
As for most reports 5'6'9'~°'13 about myocardial viabil- 
ity, the small patient population is a limitation of our 
study. Another pitfall is the comparison of echocardio- 
graphic and SPECT data, which could explain some 
discrepancies between predicted and observed functional 
changes. We did not use a normal database conceived 
for the evaluation of viability; thus all the selected 
control subjects had a ventricle of  normal size and the 
database did not take into account the changes in 
regional 99mTc-labeled sestamibi activity caused by a 
Table 2. Value of 99mTc-labeled ses tamibi  
SPECT to predict  the  postrevascuiar izat ion evolut ion 
of  the global left ventricular function 
Baseline SPECT(%) N~rateSPECT(%) p Value 
PPV 62 68 NS 
NPV 63 72 NS 
PA 63 70 NS 
The following cutoff values were used to differentiate the  patients 
with improved LVEF from the others: for baseline SPECT, defect 
severity less than 20%; for nitrate SPECT, defect severity less than 
15%. 
See Table I for abbreviations. 
dilated ventricle, 28 which is a common finding in pa- 
tients with severe asynergy. However, this problem 
should have similarly affected both baseline and nitrate 
SPECT. In contrast, the data-based quantitative analysis 
of nitrate images could have been influenced specifically 
by the direct favorable effects of  nitrates on left ven- 
tricular wall motion in asynergic regions, 29 with possible 
apparent increase of tracer activity through the partial 
volume effect. 2~ This interference cannot be excluded, 
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Figure 5. Polar map displays of patient with two-vessel disease, whose prerevascularization 
echocardiogram showed inferior akinesis and inferolateral minimal hypokinesis. Image disposition 
and abbreviations are same as in Figure 5. On baseline SPECT two territories (left circumflex and 
right coronary arteries) had significant uptake defect, but one only (right coronary artery) was 
nonviable according to severity criteria. On nitrate SPECT, left circumflex territory had nonsig- 
nificant uptake defect, whereas right coronary artery territory defect was classified as viable 
according to severity. After two-vessel angioplasty, patient no longer had effort angina and inferior 
akinesis improved significantly. 
but various points must be considered. First, the blood 
concentration of  isosorbide dinitrate after intravenous 
infusion returns to the preinfusion levels within 1 hour 
of  infusion, and the concentration of  active metabolites 
is very low by the intravenous route, because of  the 
absent first-pass hepatic metabolism. 3° Second, at the 
time of  SPECT collection all patients had returned to the 
preinfusion blood pressure and heart rate. Third, the 
evaluation of  the nitrate-induced wall motion changes at 
the moment of  tracer injection with first-pass radionu- 
clide ventriculography showed that in most cases the 
improvement of regional dysfunction was not accompa- 
nied by the finding of  an increased tracer uptake in the 
following SPECT study. 3~ 
In conclusion, our results indicate that quantitative 
99mTc-labeled sestamibi SPECT may be a reliable tech- 
nique for the detection of viable hibernating myocar- 
dium if the severity of the uptake defects is assessed. 
Furthermore, when myocardial viability is a major clini- 
cal issue the infusion of  nitrates during tracer injection 
increases accuracy. When both the analysis of  defect 
severity and the uptake enhancement with nitrates are 
performed, 99mTc-labeled sestamibi gives valuable re-  
sults for the prediction of the postrevascularization out- 
come of  asynergic areas. 
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